Drugs / JVRS-100
last change Feb 2017 re-read 2 minutes ago

JVRS-100

Developed for
influenza · leukemia
Investigated by
Colby Pharmaceutical Company · Milton S. Hershey Medical Center

Trials 3 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT00860522 Mar 2009 → Oct 2014 leukemia Milton S. Hershey Medical Center Completed No outcome recorded
Phase 1 NCT00662272 Jun → Oct 2008 influenza Colby Pharmaceutical Company Completed No outcome recorded
Phase 21 trial
Phase 2 NCT00936468 Sep 2009 → Jun 2010 influenza Colby Pharmaceutical Company Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as JVRS-100 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00936468
2

NCT00860522

NCT00662272